NXDR Nextdoor Holdings Inc climbs 556 percent on Q4 2025 EPS beat and 42 percent year over year revenue growth RIGL Rigel Pharmaceuticals Inc climbs two percent after Q4 2025 results even as EPS falls short of analyst forecasts Market Turn Technology Outperforms as Market Ups